Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Mochida Pharmaceutical

Market Cap: JP¥111.5b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

KYORIN Pharmaceutical

Market Cap: JP¥87.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Kaken Pharmaceutical

Market Cap: JP¥144.8b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Takara Bio

Market Cap: JP¥112.5b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.